Sunday, May 5, 2024
Facebook Linkedin Twitter
HomeTagsRomlusevimab

Romlusevimab

Biotechnology

Brii Biosciences Announces Commercial Launch of its Amubarvimab/Romlusevimab Combination Therapy for COVID-19 in China

PR Newswire -
Brii Biosciences Limited a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, and TSB Therapeutics...
Biotechnology

Brii Bio Announces Amubarvimab/Romlusevimab Combination Retains Neutralizing Activity Against Omicron SARS-CoV-2 Variant

PR Newswire -
Brii Biosciences Limited , a multi-national company developing innovative therapies for diseases with significant unmet medical needs and large public health burdens, announced new...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us